Register or Sign in to Save this opportunity, or Send an Inquiry.
Allerzero
Korea Health Industry Development Institute (KHIDI) South Korea flag South Korea
Abstract ID:
asthma, atopic dermatitis, allergic rhinitis
Send an Inquiry
RE:
Participants
You

The Company’s technology concentration includes research and development on natural substances that can be used in foods, medical supplies, cosmetics and daily products. With this base technology, the Company succeeded in commercializing a 100% natural substance-based acaricide product for house dust mites, which is a major cause of allergic disease such as asthma, atopic dermatitis and allergic rhinitis.


‘Allerzero,’ the dust mite extermination product that the Company developed, has various advantages in terms of side-effects, cost-effectiveness and convenience of use compared to other synthetic acaricides or laborious exterminating methods such as special vaccuums or professional services. In addition, as people show increasing concern and unease regarding allergic diseases caused by vermin, Allerzero is expected to show tremendous growth and attract much attention worldwide.

GO PREMIUM TO GET PATENT INFORMATION
Type of Business Relationship Sought
US6855348B2
FEATURED
Last Updated Jun 2016
Technology Type THERAPEUTIC
Phase of Development CLINICAL TRIALS
GOVERNMENT INSTITUTE

Opportunity Contact